Among adults with type 2 diabetes (T2D) initiating second-line antidiabetic medication (ADM) therapy, the short-term cardiovascular (CV) outcomes of glucagon-like peptide-1 (GLP-1) receptor agonists, sodium-glucose cotransporter 2 (SGLT-2) inhibitors, and dipeptidyl peptidase 4 (DPP-4) inhibitors were similar, a recent study found. The cohort study included 132,737 adults (aged 45-64 years) with T2D and examined the association of second-line ADM classes with major adverse CV events. Researchers found:
- GLP-1 receptor agonists, DPP-4 inhibitors, and SGLT-2 inhibitors were associated with similar CV outcomes.
- Sulfonylureas and basal insulin were associated with comparatively higher CV risk.
- Clinicians may consider prescribing newer ADM classes more routinely after metformin.
O’Brien MJ, Karam SL, Wallia A, et al. Association of second-line antidiabetic medications with cardiovascular events among insured adults with type 2 diabetes. JAMA Netw Open. 2018;1(8):e186125. doi:10.1001/jamanetworkopen.2018.6125.
This Week's Must Reads
Combination model predicts imminent preeclampsia, Ciobanu A et al. Am J Obstet Gynecol. 2019 Feb 7. doi. org/10.1016/j.ajog.2019.01.235
Delayed cord clamping didn’t drop maternal hemoglobin in term cesarean deliveries, Purisch S. et al. Am J Obstet Gynecol. 2019 Jan;220(1):S37-38, Abstract 47
Dental device borrowed from sports world no help in pushing, Bergh E et al. Am J Obstet Gynecol. 2019 Jan;220(1):S39, Abstract 49
Enterovirus in at-risk children associated with later celiac disease, Kahrs CR et al. BMJ. 2019 Feb 13. doi: 10.1136/bmj.l231
Must Reads in Diabetes
Hospitalization Rates in Young-Onset Diabetes, Ann Intern Med; ePub 2019 Jan 15; Ke, Lau, et al
Long-Term Absolute Risk for CVD by FG Level, Diabetes Care; ePub 2019 Jan 7; Bancks, et al
Prediabetes Status & Lifestyle Modification , J Am Board Fam Med; 2019 Jan 4; Owei, et al
Second-Line ADMs & CV Events in T2D, JAMA Netw Open; ePub 2018 Dec 21; O’Brien, et al
Rotating Night Shift Work & Risk of T2D, BMJ; ePub 2018 Nov 21; Shan, Li, et al